Effects of Clioquinol on Metal-Triggered Amyloid-β Aggregation Revisited
- 23 September 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 48 (20) , 9596-9598
- https://doi.org/10.1021/ic9014256
Abstract
Amyloid-β (Aβ) plaques are largely associated with the neuropathogenesis of Alzheimer’s disease (AD). Metal ions such as CuII and ZnII have been implicated as contributors to their formation and deposition. Metal chelators have been used to modulate metal-induced Aβ aggregation. The bidentate ligand clioquinol (CQ) presents an effective influence on metal-involved Aβ aggregation, which has been explained through its metal chelation and is generally monitored by fluorescence and turbidity assays in vitro. The studies herein, however, suggest that the effects of CQ on metal-driven Aβ aggregation may not be visualized accurately by both assays. Subsequently, the present work demonstrates that CQ is able to chelate metal ions from metal−Aβ species and to assist, in part, in the disaggregation of Aβ aggregates, but it could not completely hinder the progression of Aβ aggregation.This publication has 28 references indexed in Scilit:
- The chemistry of Alzheimer’s diseaseChemical Society Reviews, 2009
- Brain proteins that mind metals: a neurodegenerative perspectiveDalton Transactions, 2009
- Structural Studies of Copper(I) Complexes of Amyloid‐β Peptide Fragments: Formation of Two‐Coordinate Bis(histidine) ComplexesAngewandte Chemie International Edition in English, 2008
- Metals in Alzheimer's and Parkinson's DiseasesPublished by Elsevier ,2008
- Three Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and IronBiochemistry, 2007
- Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeuticsJournal of Neurochemistry, 2006
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- The metallobiology of Alzheimer's diseasePublished by Elsevier ,2003
- Zinc takes the center stage: its paradoxical role in Alzheimer’s diseaseBrain Research Reviews, 2002
- Metal complexing agents as therapies for Alzheimer’s diseaseNeurobiology of Aging, 2002